Early administration of terbutaline in severe pediatric asthma may reduce incidence of acute respiratory failure.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal titleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Publication Begin page207
Publication End page10
MetadataShow full item record
AbstractBackground: Severe pediatric asthma, if not immediately and aggressively treated, may progress to acute respiratory failure requiring mechanical ventilation in the pediatric intensive care unit (PICU). Intravenous (IV) terbutaline, a β2 agonist, is dispensed when the initial treatment does not improve the clinical condition. Objective: To investigate the influence of early initiation of IV terbutaline on the incidence of acute respiratory failure requiring mechanical ventilation in severe pediatric asthma. Methods: A retrospective chart review was conducted of 120 subjects (35 patients from an outside hospital emergency department [ED] with late start of terbutaline and 85 patients from the authors' hospital ED with early initiation of IV terbutaline) admitted to the PICU with severe asthma treated with continuous IV terbutaline. Responses to terbutaline treatment and outcomes were evaluated. Results: Patients transported from outlying hospital EDs had shorter pre-PICU mean durations of IV terbutaline than those transferred from the authors' ED (0.69 ± 1.38 and 2.91 ± 2.47 hours, respectively, P = .001). Twenty-one of 35 patients (60%) from outlying EDs required mechanical ventilation compared with 14 of 85 patients (16%) from the authors' ED (P = .001). Durations of pre-PICU terbutaline infusion for patients requiring mechanical ventilation were significantly shorter than those with no such requirement (P = .015). Conclusion: The results of the present study, conducted in the largest number of subjects to date, suggest that early administration of continuous terbutaline in the ED may decrease acute respiratory failure and the need for mechanical respiratory (invasive and noninvasive) support in severe pediatric asthma.
CitationDoymaz S, Schneider J, Sagy M. Early administration of terbutaline in severe pediatric asthma may reduce incidence of acute respiratory failure. Ann Allergy Asthma Immunol. 2014 Mar;112(3):207-10. doi: 10.1016/j.anai.2014.01.003. Epub 2014 Jan 25. PMID: 24468309.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Copyright © 2014 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
- Duration of mechanical ventilation in life-threatening pediatric asthma: description of an acute asphyxial subgroup.
- Authors: Maffei FA, van der Jagt EW, Powers KS, Standage SW, Connolly HV, Harmon WG, Sullivan JS, Rubenstein JS
- Issue date: 2004 Sep
- Intravenous β agonists and severe pediatric asthma exacerbation: time for a closer look at terbutaline?
- Authors: Kantor DB, Phipatanakul W
- Issue date: 2014 Mar
- Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus.
- Authors: Bogie AL, Towne D, Luckett PM, Abramo TJ, Wiebe RA
- Issue date: 2007 Jun
- Severe acute asthma in a community hospital pediatric intensive care unit: a ten years' experience.
- Authors: Paret G, Kornecki A, Szeinberg A, Vardi A, Barzilai A, Augarten A, Barzilay Z
- Issue date: 1998 Apr
- Helium-oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation.
- Authors: Abd-Allah SA, Rogers MS, Terry M, Gross M, Perkin RM
- Issue date: 2003 Jul